Antibiotic compositions for treatment of the eye, ear and nose

A composition, hydration technology, application in ear and nose infection, treatment of eye field, can solve the problem of limited efficacy, anti-oral antibiotics and the risk of pathogen resistance etc.

Inactive Publication Date: 2005-08-10
ALCON LAB INC
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Use of oral antibiotics for ear infections in young children has limited efficacy and poses serious risk of pathogen resistance to oral antibiotics

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibiotic compositions for treatment of the eye, ear and nose
  • Antibiotic compositions for treatment of the eye, ear and nose
  • Antibiotic compositions for treatment of the eye, ear and nose

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Eye / Ear / Nose Solution

[0066] components Amount (wt%)

[0067] Mofloxacin 0.35

[0068] Sodium acetate 0.03

[0069] Acetic acid 0.04

[0070] Mannitol 4.60

[0071] EDTA0.05

[0072] Benzalkonium chloride 0.006

[0073] Appropriate amount of water, up to 100

Embodiment 2

[0075] Eye / Ear / Nasal Suspension

[0076] components Amount (wt%)

[0077] Mofloxacin 0.3

[0078] Dexamethasone, micronized 0.10

[0079] USP

[0080] Benzalkonium Chloride 0.01

[0081] Disodium edetate, 0.01

[0082] USP

[0083] Sodium Chloride, USP 0.3

[0084] Sodium sulfate, USP 1.2

[0085] Tyloxapor, USP 0.05

[0086] Hydroxyethylcellulose 0.25

[0087] Sulfate and / or Hydroxide qs for pH adjustment

[0088] Sodium, NF round to 5.5

[0089] Pure water, USP qs, to 100

Embodiment 3

[0091] eye ointment

[0092] components Amount (wt%)

[0093] Mofloxacin 0.35

[0094] Mineral Oil, USP 2.0

[0095] White petrolatum, USP QS, to 100

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.

Description

[0001] This application is a divisional application filed on September 29, 1999, application number 99811509.6, and titled "Antibiotic Composition for Treating Eyes, Ears and Nose". technical field [0002] The present invention relates to topical antibiotic pharmaceutical compositions for the treatment of eye, ear and nose infections, particularly bacterial infections, and methods of treating eye, ear and nose infections by applying these compositions to said affected tissues. The compositions and methods of the present invention are based on the use of a new class of antibiotics. Compositions of the present invention may also contain one or more anti-inflammatory agents. Background technique [0003] The use of quinolone antibiotics to treat infections represents the current state of the art in the field of ophthalmic compositions and methods of treatment. For example, an ophthalmic composition containing the quinolone ciprofloxacin is marketed by the company Alcon Labora...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D471/04A61K31/00A61K31/435A61K31/47A61K31/4709A61K31/535A61K31/5383A61K31/5575A61K31/56A61K31/57A61K31/573A61K45/00A61K45/06A61P11/02A61P27/02A61P27/16A61P31/04
CPCA61K31/5383A61K45/06A61K31/4709A61K31/57A61K9/0043A61K9/0046A61K9/0048A61P11/02A61P11/06A61P27/02A61P27/16A61P29/00A61P31/00A61P31/02A61P31/04A61P43/00A61K31/535A61K31/47A61K2300/00A61K31/5365
Inventor G·卡格尔R·L·阿布希尔D·W·斯特罗曼J·M·扬尼
Owner ALCON LAB INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products